Influenza infection attracts pneumonia bacteria

Key points
- May 22, 2002 -- Lung cells infected with the influenza A virus are more likely to bind with bacteria that cause pneumonia than uninfected cells, but this phenomenon can be reversed with antiviral treatment.
- Horvat and her colleagues examined the relationship between the binding of S. pneumoniae bacteria to a lung epithelial cell line (the cells that line the respiratory system) with and without influenza A infection.
- Preliminary studies showed that after 24, 48 or 72 hours of viral infection, the bacteria bound to the influenza-infected cells 4 to 10 times higher than uninfected cells.
- “An influenza-infected lung epithelial cell will bind more S. pneumoniae bacteria than uninfected cells.
SALT LAKE CITY – May 22, 2002 -- Lung cells infected with the influenza A virus are more likely to bind with bacteria that cause pneumonia than uninfected cells, but this phenomenon can be reversed with antiviral treatment. Researchers from the University of Kansas Medical Center present their findings today at the 102nd General Meeting of the American Society for Microbiology. “Bacterial pneumonia caused by Streptococcus pneumoniae can occur secondary to viral infections such as influenza. Previous studies have shown that by treating the influenza virus with Tamiflu, a neuraminidase inhibitor that attacks the influenza virus at the cellular level, secondary complications such as pneumonia can be reduced,” says Dr. Rebecca Horvat, one of the researchers on the study.
Dr. Horvat and her colleagues examined the relationship between the binding of S. pneumoniae bacteria to a lung epithelial cell line (the cells that line the respiratory system) with and without influenza A infection.
Preliminary studies showed that after 24, 48 or 72 hours of viral infection, the bacteria bound to the influenza-infected cells 4 to 10 times higher than uninfected cells. When the flu virus was treated with Tamiflu, the increased binding was reversed.
“An influenza-infected lung epithelial cell will bind more S. pneumoniae bacteria than uninfected cells. Treatment with Tamiflu at doses used to treat influenza infections can prevent this increased bacterial binding, and perhaps prevent post-influenza complications, such as pneumonia,” says Dr. Horvat.
S. pneumoniae continues to be the leading cause of community-acquired pneumonia worldwide. Although the ability of bacteria to bind to host cells is the first step in the process of infection, few studies have correlated S. pneumoniae cell binding with the severity of lower respiratory tract infections. Dr. Horvat notes that this study has implications only for influenza A infections and additional research must be done on influenza B infection.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsIncreasing secondary education protects against HIV infection
Longer secondary schooling substantially reduces the risk of contracting HIV, particularly for girls, according to new research from Botswana published in The Lancet Global Health journal. The researchers estimate that…
30 June 2015
NewsReenergizing antibiotics in the war against infections
Antibiotics are the mainstay in the treatment of bacterial infections, and together with vaccines, have enabled the near eradication of infectious diseases like tuberculosis, at least in developed countries. However,…
25 June 2015
NewsUCLA research offers more evidence for possible link between cocaine use and HIV infection
New UCLA research offers further evidence that cocaine use disrupts the immune system, making people who use it more likely to become infected with HIV. In research published online June 18 in the peer-reviewed journal…